Whey Protein Low Carb Formula is suitable both for male and female athletes, as it promotes healthy and stable muscle mass building. Besides, this formula is rich in special ingredients like immunoglobulins, which boost the immune system of an athlete and stimulate metabolism. Therefore, this supplement can be used even by those, who work on body mass lowering and making efforts on effective weight management.

Muscle Advance Whey Protein is very beneficial for all today’s bodybuilders and athletes as a natural supplement which can increase endurance and vigor. It goes in two flavors, chocolate and vanilla, and can be easily mixed into milk or water. This formula is packed with a variety of vitamins, from A to E, is aspartame free and has low glycemic index. Incorporate this supplement in your daily diet (it should be taken twice a day, in the morning and before going to bed), and enjoy the benefits of this natural solution for effective muscle building, as well as for achieving lasting and prompt results.

Life Extension® offers whey protein powders in four flavors that contain added lactoferrin. Life Extension uses a production method that produces a high quality whey protein isolate. Using a low temperature microfiltration technique, it is possible to produce a 98% undenatured whey protein isolate that retains all the important sub-fractions, such as lactoferrin, a strong antioxidant with immune-supporting properties.

Link under the cut.

Life Extension

In the October 2, 2009 issue of the journal Cell, Pankaj Kapahi, PhD and colleagues identify the mechanism of the extension of life span observed in flies whose diets were modified by lowering the level of yeast relative to sucrose (the source of carbohydrates in the flies’ diets). By examining the expression of genes in restricted flies, Dr Kapahi and his associates found that, although protein synthesis was reduced on a global level, the activity of specific genes involved in the production of energy within the mitochondria increased. According to Dr Kapahi, this activity, which occurs at the level of conversion of RNA to protein, is involved in dietary restriction’s protective effects. Flies receiving low protein diets showed increased activity of a protein known as d4EBP, which is part of a signaling pathway called TOR (target of rapamycin) that influences cell growth in response to the availability of nutrients. (Rapamycin, a drug that has many medical uses, was recently shown to increase the lifespan of aged mice.) While flies on a low protein diet experienced a significant extension of lifespan compared to flies whose diets were nonrestricted, knocking out the gene for d4EBP diminished the effect, and restoring d4EBP expression enhanced it.

The findings question the wisdom of popular high protein weight loss diets. “In flies, we see that the long-lived diet is a low protein diet and what we have found here is a mechanism for how that may be working.” Dr Kapahi stated.

The study is the first genome-wide investigation of how proteins are translated in dietary restricted organisms. “Our study shows that dietary restriction can enhance mitochondrial function hence offsetting the age-related decline in its performance,” Dr Kapahi concluded. “There have been correlative studies that show mitochondria change with dietary restriction; this research provides a causal relationship between diet and mitochondrial function.”

Asahi-Kasei

Originally focused on the fibers and chemicals business sectors, today Asahi Kasei is growing through diversification into the fields of housing, health care and electronics. Asahi Kasei Corporation has seven constituent corporations – Asahi Kasei Fibers, Asahi Kasei Chemicals, Asahi Kasei Life & Living, Asahi Kasei Construction Materials, Asahi Kasei Homes, Asahi Kasei EMD and Asahi Kasei Pharma. Special emphasis is placed on R&D in the fields of electronics, health care, environmental preservation, and energy conservation.

Commenting on this announcement, Purely Proteins’ Chief Executive Officer, Dr. David Bailey, said, “This is a significant development for Purely Proteins as we move from being a service company into a product-based discovery company. Our integrated ligand discovery platform allows the parallel development of affinity ligands for many proteins simultaneously, permitting rapid optimisation of purification processes. We have selected a core set of high- value therapeutic targets for this program, which will be partnered prior to commercialisation. This will allow PP to capture more value from its technology platform without significantly increasing the risk for its investors.”

Purely Proteins

Purely Proteins has been established to exploit the increasing need for and use of human proteins in human medical research. The company purifies suites of human proteins, as both drug targets and bio-therapeutics, using proprietary processes that ensure both high purity and biological activity. Purely Proteins also offers ligand screening services, backed by state-of-the-art informatics, to examine therapeutic targeting to these proteins.